Autopsy report · NCT00529633

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients

“Low enrollment -- We could not recruit patients willing to be enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 3 months before it stopped.
• 16 participants enrolled.
• Results were posted on the registry 6 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

George A. Kaysen, M.D.

Sponsor type

University, hospital or other

Conditions

Hypoalbuminemia

Interventions

Thalidomide; Sugar pill

Participants

16

Sites

1

Countries

United States

Trials that died the same way

• Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
  “Lack of Patient Enrollment” (84% match in meaning)
• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
  “Inadequate patient enrollment” (82% match in meaning)
• Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital
  “Insufficient enrollment. Reasons for low enrollment were low eligibility, and difficulty contacting patients.” (81% match in meaning)
• Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
  “Insufficient patient enrollment.” (81% match in meaning)
• Tacks Versus Glue for Mesh Fixation in Laparoscopic Ventral Hernia Repair Treating Defects Between 2 and 5 cm Width
  “Limited patient enrollment” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.